Clinical Trial

Comparison of CT and MR (VI-RADS) Imaging for Local Bladder Cancer Staging

Recruiting
View on ClinicalTrials.gov →
Summary
This prospective diagnostic accuracy study compares computed tomography (CT) and multiparametric magnetic resonance imaging (MRI) using the Vesical Imaging-Reporting and Data System (VI-RADS) for local staging of newly diagnosed bladder cancer. All participants undergo both imaging modalities prior to transurethral resection of the bladder tumor (TURBT) or cystectomy. Histopathology serves as the reference standard.
Trial Details
NCT Number NCT07602010
Lead Sponsor Oslo University Hospital
Conditions Bladder Cancer, Urothelial Carcinoma (UC), Muscle Invasive Bladder Cancer (MIBC), Non Muscle Invasive Bladder Cancer
Enrollment 150 participants
Start Date 2026-04-22
Primary Completion 2028-04-30 (estimated)
Study Completion 2028-10-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-22